Evolus, Inc. (EOLS)

NASDAQ: EOLS · Real-Time Price · USD

5.35

-0.18 (-3.25%)

At close: Mar 9, 2026, 4:00 PM EDT

5.37

+0.02 (0.37%)

After-hours: Mar 9, 2026, 7:56 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Delivering Medical Aesthetic Products to the Cash-pay Aesthetic Market	297.18M	266.27M	202.09M	148.62M	99.67M
Delivering Medical Aesthetic Products to the Cash-pay Aesthetic Market Growth	11.61%	31.76%	35.98%	49.10%	76.29%
Total	297.18M	266.27M	202.09M	148.62M	99.67M
Total Growth	11.61%	31.76%	35.98%	49.10%	76.29%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	146.15M	-
International	2.47M	-
Total	148.62M	-

Source: S&P Global Market Intelligence.